0001225208-15-020421.txt : 20151109 0001225208-15-020421.hdr.sgml : 20151109 20151105120243 ACCESSION NUMBER: 0001225208-15-020421 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151104 FILED AS OF DATE: 20151105 DATE AS OF CHANGE: 20151105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC CENTRAL INDEX KEY: 0000105770 STANDARD INDUSTRIAL CLASSIFICATION: FABRICATED RUBBER PRODUCTS, NEC [3060] IRS NUMBER: 231210010 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 GORDON DR STREET 2: P O BOX 645 CITY: LIONVILLE STATE: PA ZIP: 19341-0645 BUSINESS PHONE: 6105942900 MAIL ADDRESS: STREET 1: 101 GORDON DRIVE STREET 2: PO BOX 645 CITY: LIONVILLE STATE: PA ZIP: 19341-0645 FORMER COMPANY: FORMER CONFORMED NAME: WEST CO INC DATE OF NAME CHANGE: 19990405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Malone Daniel CENTRAL INDEX KEY: 0001527326 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-08036 FILM NUMBER: 151199553 MAIL ADDRESS: STREET 1: 101 GORDON DRIVE CITY: LIONVILLE STATE: PA ZIP: 19341 4 1 doc4.xml X0306 4 2015-11-04 0000105770 WEST PHARMACEUTICAL SERVICES INC WST 0001527326 Malone Daniel 530 HERMAN O. WEST DRIVE EXTON PA 19341 1 Vice President & Controller Common Stock 2015-11-04 4 M 0 4456.0000 17.2250 A 27082.8536 D Common Stock 2015-11-04 4 S 0 4456.0000 61.6500 D 22626.8536 D Stock Option (Right to Buy) 17.2250 2015-11-04 4 M 0 4456.0000 17.2275 D 2007-06-22 2016-06-22 Common Stock 4456.0000 0.0000 D The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $61.58 to $61.69, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. Reflects additional shares purchased through dividend reinvestments based on most recent plan statement. Joanne K. Boyle as Agent for Daniel Malone 2015-11-05